Genomic Applications in Prevention and Practice (GAPPNET) A Scientific Foundation for Implementing Genomics and Precision Medicine Applications in Cancer Control and Prevention

这项协议的目的是有效地将癌症基因组学和精准医学转化为临床和公共卫生项目，并负责任地推进，以减轻美国癌症发生和死亡的负担。根据这项协议，OGPPH将向DCCPS提供技术援助和合作，以1)识别和传播关于新出现的癌症基因组和精确医学应用的信息；2)加强医疗保健-公共卫生合作和伙伴关系，将证据转化为临床和公共卫生行动；3)开发和传播工具和资源，帮助将癌症基因组学纳入计划，4)为最佳做法和实施方式进行基于证据的评估和健康影响分析；5)制定人口指标和指标，以成功地将癌症精确医学和基因组学纳入人口健康计划；6)向公共卫生部门和保健提供者提供培训和咨询；7)为公共卫生和保健提供者以及普通公众开发通信产品。 根据这项协议，DCCPS将在2020财年将175K转移到OGPPH。该协议的条款将每年重新审议，并根据对DCCPS的好处进行评估。

The purpose of this agreement is to effectively translate and responsibly advance cancer genomics and precision medicine into clinical and public health programs that can reduce the burden of cancer occurrence and mortality in the US. Under the terms of this agreement, OGPPH will provide technical assistance and collaborations to DCCPS to 1) identify and disseminate information about emerging cancer genomic and precision medicine applications; 2) strengthen healthcare-public health collaborations and partnerships in translating evidence into clinical and public health action; 3) develop and disseminate tools and resources to help integrate cancer genomics into programs, 4) conduct evidence-based evaluations and health impact analyses for best practices and ways of implementation; 5) develop population metrics and indicators for successful integration of cancer precision medicine and genomics into population health programs; 6) provide training and consultation to public health departments and health care providers; 7) develop communication products for public health and healthcare providers and for the general public. Under this agreement, DCCPS will transfer 175K to OGPPH in FY2020. The terms of the agreement will be revisited every year and evaluated on the basis of benefits to DCCPS.